Filtros de búsqueda

Lista de obras de

A baseline tool for predicting response to peginterferon alfa-2a in HBeAg-positive patients with chronic hepatitis B

artículo científico publicado en 2018

A genotype-specific baseline score predicts post-treatment response to peginterferon alfa-2a in hepatitis B e antigen-negative chronic hepatitis B

scientific article published on 26 July 2018

A heterogeneous hierarchy of co-regulatory receptors regulates exhaustion of HCV-specific CD8 T cells in patients with chronic hepatitis C.

artículo científico publicado en 2014

A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel

artículo científico publicado en 2011

A transient early HBV DNA increase during PEG-IFNα therapy of hepatitis D indicates loss of infected cells and is associated with HDV RNA and HBsAg reduction

artículo científico publicado en 2020

Addressing barriers to the prevention, diagnosis and treatment of hepatitis B and C in the face of persisting fiscal constraints in Europe: report from a high level conference

artículo científico publicado en 2016

Adenosine and IFN-{alpha} synergistically increase IFN-gamma production of human NK cells.

artículo científico publicado en 2008

All-oral, interferon-free therapies for patients with chronic genotype 1 hepatitis C virus infection

artículo científico publicado en 2014

Altered effector functions of NK cells in chronic hepatitis C are associated with IFNL3 polymorphism.

artículo científico publicado en 2015

Anti-HDV IgM as a marker of disease activity in hepatitis delta

artículo científico publicado en 2014

Antiviral treatment and liver-related complications in hepatitis delta

artículo científico publicado en 2016

Applicability of Hepatitis C Virus RNA Viral Load Thresholds for 8-Week Treatments in Patients With Chronic Hepatitis C Virus Genotype 1 Infection.

artículo científico publicado en 2016

Assay for Hepatitis B Core-related Antigen Identify Patients With High Viral Load: Systematic Review and Meta-analysis of Individual Participant Data

scientific article published on 29 April 2020

Association Between Type 2 Diabetes Mellitus, HbA1c and the Risk for Spontaneous Bacterial Peritonitis in Patients with Decompensated Liver Cirrhosis and Ascites

artículo científico publicado en 2018

Baseline risk factors determine lack of biochemical response after SVR in chronic hepatitis C patients treated with DAAs

artículo científico publicado en 2019

CD8 T cell cross-reactivity networks mediate heterologous immunity in human EBV and murine vaccinia virus infections

artículo científico publicado en 2010

CD8 memory T cells: cross-reactivity and heterologous immunity.

artículo científico publicado en 2004

Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper

scientific article published on 02 April 2020

Caspase activation is required for antiviral treatment response in chronic hepatitis C virus infection

artículo científico publicado en 2006

Challenges in warranting access to prophylaxis and therapy for hepatitis B virus infection.

artículo científico publicado en 2017

Chronic Viral Liver Diseases: Approaching the Liver Using T Cell Receptor-Mediated Gene Technologies

scientific article published on 16 June 2020

Chronic hepatitis C virus infection irreversibly impacts human natural killer cell repertoire diversity.

artículo científico publicado en 2018

Chronic hepatitis E virus infection beyond transplantation or human immunodeficiency virus infection.

artículo científico publicado en 2014

Chronic hepatitis delta virus infection leads to functional impairment and severe loss of MAIT cells

artículo científico publicado en 2019

Chronic hepatitis B and D (delta) : Current and future treatments

artículo científico publicado en 2018

Clearance of chronic HCV infection during acute delta hepatitis.

artículo científico publicado en 2007

Clearance of low levels of HCV viremia in the absence of a strong adaptive immune response

artículo científico publicado en 2007

Clinical Practice Guidelines of the European Association for the study of the Liver - Advancing methodology but preserving practicability

artículo científico publicado en 2018

Clinical and virological heterogeneity of hepatitis delta in different regions world-wide: The Hepatitis Delta International Network (HDIN).

artículo científico publicado en 2017

Clinical impact of pharmacokinetic interactions between the HCV protease inhibitor Simeprevir and frequently used concomitant medications

artículo científico publicado en 2018

Clinical value of on-treatment HCV RNA levels during different sofosbuvir-based antiviral regimens

artículo científico publicado en 2016

Clonal exhaustion as a mechanism to protect against severe immunopathology and death from an overwhelming CD8 T cell response.

artículo científico publicado en 2013

Commutability and concordance of four hepatitis B virus DNA assays in an international multicenter study

artículo científico publicado en 2017

Comprehensive phenotyping of regulatory T cells after liver transplantation.

artículo científico publicado en 2015

Compromised function of natural killer cells in acute and chronic viral hepatitis.

artículo científico publicado en 2013

Contrasting Timing of Virological Relapse After Discontinuation of Tenofovir or Entecavir in Hepatitis B e Antigen-Negative Patients

artículo científico publicado en 2018

Correlation between the Elecsys HBsAg II assay and the Architect assay for the quantification of hepatitis B surface antigen (HBsAg) in the serum

artículo científico publicado en 2011

Costs of guideline-based treatment of hepatitis B patients in Germany

artículo científico publicado en 2012

Cross-genotype-reactivity of the immunodominant HCV CD8 T-cell epitope NS3-1073.

artículo científico publicado en 2008

Cross-genotype-specific T-cell responses in acute hepatitis E virus (HEV) infection.

artículo científico publicado en 2016

Cross-reactive influenza virus-specific CD8+ T cells contribute to lymphoproliferation in Epstein-Barr virus-associated infectious mononucleosis

artículo científico publicado en 2005

Current seroprevalence, vaccination and predictive value of liver enzymes for hepatitis B among refugees in Germany

artículo científico publicado en 2016

Cytomegalovirus-Driven Adaptive-Like Natural Killer Cell Expansions Are Unaffected by Concurrent Chronic Hepatitis Virus Infections

artículo científico publicado en 2017

Defining virus-specific CD8+ TCR repertoires for therapeutic regeneration of T cells against chronic hepatitis E

scientific article published on 14 June 2019

Delayed versus immediate treatment for patients with acute hepatitis C: a randomised controlled non-inferiority trial

artículo científico publicado en 2013

Detection of low HCV viraemia by repeated HCV RNA testing predicts treatment failure to triple therapy with telaprevir.

artículo científico publicado en 2013

Development and evaluation of a baseline-event-anticipation score for hepatitis delta

artículo científico publicado en 2014

Diagnostics and therapy of hepatitis

artículo científico publicado en 2009

Different kinetics of liver stiffness using shear wave elastography in patients with chronic hepatitis C infection treated with interferon-free regimens

artículo científico publicado en 2019

Direct-Acting Antiviral-Induced Hepatitis C Virus Clearance Does Not Completely Restore the Altered Cytokine and Chemokine Milieu in Patients With Chronic Hepatitis C.

artículo científico publicado en 2016

Dominance of hepatitis C virus (HCV) is associated with lower quantitative hepatitis B surface antigen and higher serum interferon-γ-induced protein 10 levels in HBV/HCV-coinfected patients

artículo científico publicado en 2015

Donor T cells primed on leukemia lysate-pulsed recipient APCs mediate strong graft-versus-leukemia effects across MHC barriers in full chimeras.

artículo científico publicado en 2009

Dose-dependent impact of proton pump inhibitors on the clinical course of spontaneous bacterial peritonitis.

artículo científico publicado en 2018

Drug-Drug Interactions With Novel All Oral Interferon-Free Antiviral Agents in a Large Real-World Cohort.

artículo científico publicado en 2015

Dual function of the NK cell receptor 2B4 (CD244) in the regulation of HCV-specific CD8+ T cells

artículo científico publicado en 2011

Early monotherapy with pegylated interferon alpha-2b for acute hepatitis C infection: the HEP-NET acute-HCV-II study

artículo científico publicado en 2006

Editorial: which factors influence HBsAg levels in HBV-infected patients?

scientific article published on 01 August 2020

Effect of H. pylori on the expression of TRAIL, FasL and their receptor subtypes in human gastric epithelial cells and their role in apoptosis

artículo científico publicado en 2004

Effect of peptide pools on effector functions of antigen-specific CD8+ T cells.

artículo científico publicado en 2009

Effects of HDV infection and pegylated interferon α treatment on the natural killer cell compartment in chronically infected individuals

artículo científico publicado en 2014

Eligibility and safety of the first interferon-free therapy against hepatitis C in a real-world setting

artículo científico publicado en 2015

Eligibility and safety of triple therapy for hepatitis C: lessons learned from the first experience in a real world setting

artículo científico publicado en 2013

Elimination of hepatitis C virus has limited impact on the functional and mitochondrial impairment of HCV-specific CD8+ T cell responses

scientific article published on 08 July 2019

Embedding T cells in the matrix.

artículo científico publicado en 2004

Entecavir - options and obstacles of an effective treatment for chronic hepatitis B

artículo científico publicado en 2009

Fate and function of hepatitis-C-virus-specific T-cells during peginterferon-alpha2b therapy for acute hepatitis C.

artículo científico publicado en 2007

Fate of goblet cells in experimental colitis

artículo científico publicado en 2002

Final analysis of the international observational S-Collate study of peginterferon alfa-2a in patients with chronic hepatitis B

scientific article published on 10 April 2020

Frequency of Potential Drug-Drug Interactions in the Changing Field of HCV Therapy

artículo científico publicado en 2020

Frequency, Private Specificity, and Cross-Reactivity of Preexisting Hepatitis C Virus (HCV)-Specific CD8+ T Cells in HCV-Seronegative Individuals: Implications for Vaccine Responses.

artículo científico publicado en 2015

Frequency, characteristics and impact of multiple consecutive nosocomial infections in patients with decompensated liver cirrhosis and ascites

scientific article published on 13 March 2020

Fulminant hepatic failure due to chemotherapy-induced hepatitis B reactivation: role of rituximab.

artículo científico publicado en 2010

Functional and phenotypic characterization of peptide-vaccine-induced HCV-specific CD8+ T cells in healthy individuals and chronic hepatitis C patients.

artículo científico publicado en 2007

Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study

artículo científico publicado en 2018

Global timing of hepatitis C virus elimination in high-income countries

artículo científico publicado en 2019

Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference

artículo científico publicado en 2019

Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference‡

artículo científico publicado en 2019

HBV-RNA Co-amplification May Influence HBV DNA Viral Load Determination

artículo científico publicado en 2020

HBsAg seroclearance with NUCs: rare but important.

artículo científico publicado en 2014

HCC Immune Surveillance and Antiviral Therapy of Hepatitis C Virus Infection

scientific article published on 18 July 2018

Hepatitis A virus infection suppresses hepatitis C virus replication and may lead to clearance of HCV.

artículo científico publicado en 2006

Hepatitis B core-related antigen (HBcrAg) levels in the natural history of hepatitis B virus infection in a large European cohort predominantly infected with genotypes A and D.

artículo científico publicado en 2015

Hepatitis B surface antigen (HBsAg) decrease and serum interferon-inducible protein-10 levels as predictive markers for HBsAg loss during treatment with nucleoside/nucleotide analogues.

artículo científico publicado en 2011

Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspective.

artículo científico publicado en 2010

Hepatitis B surface antigen concentrations in patients with HIV/HBV co-infection

artículo científico publicado en 2012

Hepatitis B surface antigen quantification: why and how to use it in 2011 - a core group report

scientific article published on 28 June 2011

Hepatitis B virus-specific T cell responses after stopping nucleos(t)ide analogue therapy in HBeAg-negative chronic hepatitis B

article

Hepatitis B – Ein Ausblick auf aktualisierte Leitlinien

artículo científico publicado en 2018

Hepatitis C in Germany: an analysis of statutory sickness funds claims data

artículo científico publicado en 2015

Hepatitis C reference viruses highlight potent antibody responses and diverse viral functional interactions with neutralising antibodies

artículo científico publicado en 2020

Hepatitis C virus core antigen testing in liver and kidney transplant recipients

artículo científico publicado en 2013

Hepatitis C virus infection from the perspective of heterologous immunity.

artículo científico publicado en 2016

Hepatitis C virus-specific T cell responses against conserved regions in recovered patients.

artículo científico publicado en 2009

Hepatitis C: individualised medicine versus one pill fits all.

artículo científico publicado en 2016

Hepatitis D virus-specific cytokine responses in patients with chronic hepatitis delta before and during interferon alfa-treatment.

artículo científico publicado en 2011

Hepatitis E Virus (HEV)-Specific T Cell Receptor Cross-Recognition: Implications for Immunotherapy

artículo científico publicado en 2019

Hepatitis E virus (HEV)-specific T-cell responses are associated with control of HEV infection

artículo científico publicado en 2012

Hepatitis E virus ORF 1 induces proliferative and functional T-cell responses in patients with ongoing and resolved hepatitis E.

artículo científico publicado en 2017

Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients

artículo científico publicado en 2010

Hepatitis associated cryoglobulinemia

artículo científico publicado en 2008

Hepatitis: No cure for hepatitis B and D without targeting integrated viral DNA?

artículo científico publicado en 2018

Historical epidemiology of hepatitis C virus (HCV) in selected countries.

artículo científico publicado en 2014

How to interpret borderline HCV antibody test results: a comparative study investigating four different anti-HCV assays.

artículo científico publicado en 2014

Human γδ T Cell Receptor Repertoires in Peripheral Blood Remain Stable Despite Clearance of Persistent Hepatitis C Virus Infection by Direct-Acting Antiviral Drug Therapy.

artículo científico publicado en 2018

Identification of Keratin 23 as a Hepatitis C Virus-Induced Host Factor in the Human Liver

scientific article published on 18 June 2019

Identification of Novel Population-Specific Cell Subsets in Chinese Ulcerative Colitis Patients Using Single-Cell RNA Sequencing

artículo científico publicado en 2021

ImPortance of IP-10 in hepatitis B

scientific article published on 24 November 2015

Impact of CD4+ blood cell count and HIV viral load on treatment response with direct acting antivirals in HIV and HCV coinfected patients: insights from the German Hepatitis C-Registry

artículo científico publicado en 2018

Impact of COVID-19 on the care of patients with liver disease: EASL-ESCMID position paper after 6 months of the pandemic

artículo científico publicado en 2020

Impaired TRAIL-dependent cytotoxicity of CD1c-positive dendritic cells in chronic hepatitis C virus infection.

artículo científico publicado en 2008

Improved immune status corresponds with long-term decline of quantitative serum hepatitis B surface antigen in HBV/HIV co-infected patients

artículo científico publicado en 2012

Improved pharmacodynamics and pharmacokinetics after i.v. application of peginterferon alfa-2a in hepatitis C null responders

artículo científico publicado en 2015

In vivo evidence for ribavirin-induced mutagenesis of the hepatitis E virus genome

artículo científico publicado en 2016

Increased Immune Response Variability during Simultaneous Viral Coinfection Leads to Unpredictability in CD8 T Cell Immunity and Pathogenesis

artículo científico publicado en 2015

Increased NK Cell Function After Cessation of Long-Term Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Is Associated With Liver Damage and HBsAg Loss.

artículo científico publicado en 2018

Inflammatory patterns in plasma associate with hepatocellular carcinoma development in cured hepatitis C cirrhotic patients

artículo científico publicado en 2020

Interferon α-stimulated natural killer cells from patients with acute hepatitis C virus (HCV) infection recognize HCV-infected and uninfected hepatoma cells via DNAX accessory molecule-1.

artículo científico publicado en 2012

Interferon-alpha-induced TRAIL on natural killer cells is associated with control of hepatitis C virus infection.

artículo científico publicado en 2010

Interferon-free cure of chronic Hepatitis C is associated with weight gain during long-term follow-up

artículo científico publicado en 2017

Interferon-free therapy of chronic hepatitis C with direct-acting antivirals does not change the short-term risk for de novo hepatocellular carcinoma in patients with liver cirrhosis

artículo científico publicado en 2017

Interpreting T-Cell Cross-reactivity through Structure: Implications for TCR-Based Cancer Immunotherapy

artículo científico publicado en 2017

Intrahepatic long-term persistence of parvovirus B19 and its role in chronic viral hepatitis

artículo científico publicado en 2009

Kurzfassung der aktualisierten S3-Leitlinie „Diagnostik und Therapie der Hepatitis B”

artículo científico publicado en 2007

Laboratory requirements to diagnose viral hepatitis under the development of guidelines

artículo científico publicado en 2016

Late HDV RNA relapse after peginterferon alpha-based therapy of chronic hepatitis delta

artículo científico publicado en 2014

Ledipasvir plus sofosbuvir fixed-dose combination for 6 weeks in patients with acute hepatitis C virus genotype 1 monoinfection (HepNet Acute HCV IV): an open-label, single-arm, phase 2 study

artículo científico publicado en 2016

Letter: a 5-year long-term follow-up study after DAA treatment confirms a reduced HCC risk in a central European cohort of HCV patients with liver cirrhosis

artículo científico publicado en 2020

Letter: can persisting liver stiffness indicate increased risk of hepatocellular cell carcinoma after successful anti-HCV therapy? - authors' reply

scientific article published on 01 February 2016

Limited effectiveness and safety profile of protease inhibitor-based triple therapy against chronic hepatitis C in a real-world cohort with a high proportion of advanced liver disease.

artículo científico publicado en 2014

Liver stiffness across different chronic liver disease under therapy with statin in a real life cohort

scientific article published on 08 April 2020

Long-term changes in liver elasticity in hepatitis C virus-infected patients with sustained virologic response after treatment with direct-acting antivirals

artículo científico publicado en 2018

Long-term follow-up after successful interferon therapy of acute hepatitis C.

artículo científico publicado en 2004

Long-term response after stopping tenofovir disoproxil fumarate in non-cirrhotic HBeAg-negative patients - FINITE study

artículo científico publicado en 2017

Loss of anti-viral immunity by infection with a virus encoding a cross-reactive pathogenic epitope.

artículo científico publicado en 2012

MAIT cells are enriched and highly functional in ascites of patients with decompensated liver cirrhosis

artículo científico publicado en 2020

Making sense of muscle fatigue and liver lesions.

artículo científico publicado en 2007

Management of HBV and HBV/HDV-Associated Liver Cirrhosis

artículo científico publicado en 2016

Memory of mice and men: CD8+ T-cell cross-reactivity and heterologous immunity

artículo científico publicado en 2006

Multi-Omics Integration Reveals Only Minor Long-Term Molecular and Functional Sequelae in Immune Cells of Individuals Recovered From COVID-19

artículo científico publicado en 2022

Mutations in Hepatitis D Virus Allow It to Escape Detection by CD8 T Cells and Evolve at the Population Level

scientific article published on 12 February 2019

Mycophenolate mofetil in combination with recombinant interferon alfa-2a in interferon-nonresponder patients with chronic hepatitis C.

artículo científico publicado en 2002

NK cells in hepatitis C: role in disease susceptibility and therapy.

artículo científico

Narrowed TCR repertoire and viral escape as a consequence of heterologous immunity

artículo científico publicado en 2006

Narrowed TCR repertoire and viral escape as a consequence of heterologous immunity

article published in 2007

Natural killer cells act as rheostats modulating antiviral T cells

artículo científico publicado en 2011

New approaches and therapeutic modalities for the treatment of patients with chronic hepatitis C.

artículo científico publicado en 2005

New direct-acting antiviral agents for the treatment of chronic hepatitis C in 2014

artículo científico publicado en 2014

New kids on the block--step by step to an ideal HCV therapy

artículo científico publicado en 2014

New susceptibility loci for severe COVID-19 by detailed GWAS analysis in European populations

artículo científico

New viral biomarkers for Hepatitis B: Are we able to change practice?

artículo científico publicado en 2018

Nonreversible MAIT cell-dysfunction in chronic hepatitis C virus infection despite successful interferon-free therapy

artículo científico publicado en 2016

Origin, prevalence and response to therapy of hepatitis C virus genotype 2k/1b chimeras.

artículo científico publicado en 2017

PEG-IFN alpha but not ribavirin alters NK cell phenotype and function in patients with chronic hepatitis C

artículo científico publicado en 2014

Peginterferon alfa-2a plus tenofovir disoproxil fumarate for hepatitis D (HIDIT-II): a randomised, placebo controlled, phase 2 trial

scientific article published on 01 March 2019

Performance and Value of IFN-Lambda3 and IFN-Lambda4 Genotyping in Patients with Chronic Hepatitis C (CHC) Genotype 2/3 in a Real World Setting

artículo científico publicado en 2015

Performance of Roche qualitative HEV assay on the cobas 6800 platform for quantitative measurement of HEV RNA

artículo científico publicado en 2020

Performance of Three Common Hepatitis C Virus (HCV) Genotyping Assays for Identification of HCV Genotype 2/1 Chimeras

scientific article published on 25 June 2019

Personalized treatment of viral hepatitis of the present and the future : Hepatitis B, C, delta, and E

artículo científico publicado en 2017

Phase III results of Boceprevir in treatment naïve patients with chronic hepatitis C genotype 1.

artículo científico

Pneumococcal meningitis during antiviral treatment with interferon and ribavirin in a splenectomized patient with chronic hepatitis C - do not miss vaccination before starting therapy.

artículo científico publicado en 2008

Polyethylene glycol-interferon: current status in hepatitis C virus therapy

artículo científico publicado en 2002

Present and future therapy for hepatitis C virus

artículo científico publicado en 2006

Prevalence of HBV genotypes in Central and Eastern Europe

scientific article published on 01 October 2008

Prevalence of Hepatitis B, C, and D in Germany: Results From a Scoping Review

artículo científico publicado en 2020

Private specificities of CD8 T cell responses control patterns of heterologous immunity

artículo científico publicado en 2005

Prophylaxis, Diagnosis and Therapy of Hepatitis-B-Virus-(HBV-)Infection: upgrade of the guideline, AWMF-Register 021/011

artículo científico publicado en 2007

Prophylaxis, diagnosis and therapy of hepatitis B virus (HBV) infection: the German guidelines for the management of HBV infection.

artículo científico publicado en 2007

Prophylaxis, diagnosis and therapy of hepatitis C virus (HCV) infection: the German guidelines on the management of HCV infection

artículo científico publicado en 2010

Protection against vaccinia virus challenge by CD8 memory T cells resolved by molecular mimicry.

artículo científico publicado en 2006

Quantitation of large, middle and small hepatitis B surface proteins in HBeAg-positive patients treated with peginterferon alfa-2a

artículo científico publicado en 2019

Rates of sustained virological response 12 weeks after the scheduled end of direct-acting antiviral (DAA)-based hepatitis C virus (HCV) therapy from the National German HCV registry: does HIV coinfection impair the response to DAA combination therap

artículo científico publicado en 2018

Real-World Safety, Effectiveness, and Patient-Reported Outcomes in Patients with Chronic Hepatitis C Virus Infection Treated with Glecaprevir/Pibrentasvir: Updated Data from the German Hepatitis C-Registry (DHC-R)

artículo científico publicado en 2022

Real-world effect of ribavirin on quality of life in HCV-infected patients receiving interferon-free treatment.

artículo científico publicado en 2017

Real-world effectiveness and safety of glecaprevir/pibrentasvir for the treatment of patients with chronic HCV infection: a meta-analysis

scientific article published on 13 February 2020

Real-world use, effectiveness and safety of anti-viral treatment in chronic hepatitis C genotype 3 infection

artículo científico publicado en 2017

Reappearance of Effector T Cells Predicts Successful Recovery from COVID-19

scientific article published on 15 May 2020

Reappearance of effector T cells is associated with recovery from COVID-19

artículo científico publicado en 2020

Reduced dose and duration of peginterferon alfa-2b and weight-based ribavirin in patients with genotype 2 and 3 chronic hepatitis C.

artículo científico publicado en 2011

Repeated Measurements of Hepatitis B Surface Antigen Identify Carriers of Inactive HBV During Long-term Follow-up

artículo científico publicado en 2016

Reply to Liaw

scientific article published on 01 October 2018

Reply to: “Serum HBsAg kinetics in clinical prediction”

artículo científico publicado en 2017

Residual low HDV viremia is associated HDV RNA relapse after PEG-IFNa-based antiviral treatment of hepatitis delta: Results from the HIDIT-II study

artículo científico publicado en 2020

Resistance to vaccinia virus is less dependent on TNF under conditions of heterologous immunity.

artículo científico publicado en 2009

Response to Taiwan is on track of accelerating hepatitis C elimination by 2025

scientific article published on 24 April 2020

Role of soluble inflammatory mediators and different immune cell populations in early control of symptomatic acute hepatitis C virus infection

artículo científico publicado en 2019

Safety and Effectiveness of Direct-Acting Antiviral Agents for Treatment of Patients With Chronic Hepatitis C Virus Infection and Cirrhosis.

artículo científico publicado en 2016

Safety and feasibility of transjugular intrahepatic portosystemic shunt in elderly patients with liver cirrhosis and refractory ascites

artículo científico publicado en 2020

Seroprevalence of antibodies and antigens against hepatitis A-E viruses in refugees and asylum seekers in Germany in 2015.

artículo científico publicado en 2017

Sofosbuvir monotherapy fails to achieve HEV RNA elimination in patients with chronic hepatitis E - The HepNet SofE pilot study

artículo científico publicado en 2020

Sofosbuvir, velpatasvir, and voxilaprevir for patients with failure of previous direct-acting antiviral therapy for chronic hepatitis C: Results from the German Hepatitis C-Registry (DHC-R)

scientific article published on 18 September 2020

Sofosbuvir: the final nail in the coffin for hepatitis C?

artículo científico publicado en 2013

Soluble immune markers in the different phases of chronic hepatitis B virus infection

scientific article published on 01 October 2019

Specific infections in organ transplantation

artículo científico publicado en 2016

Spontaneous clearance of chronic hepatitis C after liver transplantation: are hepatitis C virus-specific T cell responses the clue?

artículo científico publicado en 2008

Stomach reduction or gastric bypass as risk factor for treatment failure after DAA therapy for hepatitis C?

artículo científico publicado en 2017

Strategies to manage hepatitis C virus (HCV) disease burden.

artículo científico publicado en 2014

Successful retreatment of a patient with chronic hepatitis C genotype 2k/1b virus with ombitasvir/paritaprevir/ritonavir plus dasabuvir.

artículo científico publicado en 2017

Sustained impact of nosocomial-acquired spontaneous bacterial peritonitis in different stages of decompensated liver cirrhosis

artículo científico publicado en 2019

Symptoms of anxiety and depression are frequent in patients with acute hepatitis C and are not associated with disease severity

artículo científico publicado en 2015

Systemic arterial blood pressure determines the therapeutic window of non-selective beta blockers in decompensated cirrhosis

scientific article published on 02 August 2019

Systemic inflammation and immune cell phenotypes are associated with neuro-psychiatric symptoms in patients with chronic inflammatory liver diseases

artículo científico publicado en 2018

TOX defines the degree of CD8+ T cell dysfunction in distinct phases of chronic HBV infection

artículo científico publicado en 2020

Ten-year follow-up of a randomized controlled clinical trial in chronic hepatitis delta

scientific article published on 24 July 2020

The German guideline for the management of hepatitis B virus infection: short version.

artículo científico publicado en 2008

The Third Signal Cytokine Interleukin 12 Rather Than Immune Checkpoint Inhibitors Contributes to the Functional Restoration of Hepatitis D Virus-Specific T Cells.

artículo científico publicado en 2016

The clinical significance of drug-drug interactions in the era of direct-acting anti-viral agents against chronic hepatitis C.

artículo científico

The hepatitis E virus: a likely cause of extrahepatic diseases!

artículo científico publicado en 2016

The impact of proton pump inhibitors on the intestinal microbiota in chronic hepatitis C patients

artículo científico publicado en 2019

The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm

artículo científico publicado en 2014

The role of HBsAg levels in the current management of chronic HBV infection

artículo científico publicado en 2014

The role of quantitative hepatitis B surface antigen revisited.

artículo científico publicado en 2016

Towards eradication of HBV: Treatment approaches and status of clinical trials

artículo científico publicado en 2021

Treating chronic hepatitis delta: The need for surrogate markers of treatment efficacy

artículo científico publicado en 2018

Treatment Extension of Pegylated Interferon Alpha and Ribavirin Does Not Improve SVR in Patients with Genotypes 2/3 without Rapid Virological Response (OPTEX Trial): A Prospective, Randomized, Two-Arm, Multicentre Phase IV Clinical Trial.

artículo científico publicado en 2015

Treatment duration in acute hepatitis C: the issue is not solved yet

artículo científico publicado en 2006

Treatment of HCV genotype 2 with sofosbuvir and ribavirin results in lower sustained virological response rates in real life than expected from clinical trials

artículo científico publicado en 2016

Treatment of acute hepatitis C-how to explain the differences?

artículo científico publicado en 2006

Treatment of acute hepatitis C: the success of monotherapy with (pegylated) interferon alpha.

artículo científico publicado en 2008

Treatment of chronic hepatitis C with PEGylated interferon and ribavirin

artículo científico publicado en 2002

Treatment of naïve patients with chronic hepatitis C genotypes 2 and 3 with pegylated interferon alpha and ribavirin in a real world setting: relevance for the new era of DAA

artículo científico publicado en 2014

Treatment with daily consensus interferon (CIFN) plus ribavirin in non-responder patients with chronic hepatitis C: a randomized open-label pilot study

artículo científico publicado en 2005

Treatment-related hemophagocytic lymphohistiocytosis secondary to checkpoint inhibition with nivolumab plus ipilimumab

artículo científico publicado en 2018

Type I Interferon Elevates Co-Regulatory Receptor Expression on CMV- and EBV-Specific CD8 T Cells in Chronic Hepatitis C.

artículo científico publicado en 2015

UEG framework for the development of high-quality clinical guidelines

scientific article published on 02 September 2020

Unexplained jaundice after squirrel bite. It's not what you look at that matters, it's what you see (H. D. Thoreanu)

artículo científico publicado en 2011

Unraveling the Hepatitis B Cure: A Hybrid AI Approach for Capturing Knowledge about the Immune System's Impact

artículo científico publicado en 2023

Utilization and effectiveness of elbasvir/grazoprevir and adoption of resistance-associated substitutions testing in real-world treatment of hepatitis C virus genotype 1A infection: results from the German Hepatitis C-Registry

scientific article published on 25 April 2020

Viral and Host Responses After Stopping Long-term Nucleos(t)ide Analogue Therapy in HBeAg-Negative Chronic Hepatitis B.

artículo científico publicado en 2016

What is new on HBsAg and other diagnostic markers in HBV infection?

artículo científico

When a respiratory pathogen turns to the skin: cutaneous tuberculosis in a lung transplant patient

artículo científico publicado en 2015

Which treatment options are validated for chronic viral hepatitis?

artículo científico publicado en 2013

Whom? When? How? Another piece of evidence for early treatment of acute hepatitis C

artículo científico publicado en 2004

[4 years of direct-acting antivirals (DAAs) in the German Hepatitis C-Registry (DHC-R)]

scientific article published on 14 January 2019

[Current Guidelines for treatment of hepatitis B. Correct diagnosis is the prerequisite.].

scientific article published on 01 January 2011

[Hepatitis E virus infection: a paradigm shift?]

artículo científico publicado en 2010

[Influence of a spontaneous bacterial peritonitis, nosocomial infections and acute-on-chronic liver failure on treatment revenues in patients with decompensated cirrhosis in Germany]

scientific article published on 18 September 2020

[Knowledge and management of hepatitis B virus infected patients in Germany]

artículo científico publicado en 2012

[One pill for all HCV-genotypes?]

artículo científico publicado en 2016

[Paradigmatic change in treatment of viral hepatitides]

artículo científico publicado en 2012

[Prevention of virus hepatitis A to E]

scientific article published on 01 March 2011

[Step-by-step toward the perfect hepatitis C treatment for all genotypes]

artículo científico publicado en 2015

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda